Select a Region
North America

Your hub for company news and information

Posted on May 25, 20235/25/23

Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

Read More
EVERSANA
Posted on May 22, 20235/22/23

Yaral Pharma Partners with EVERSANA to Support the Commercialization of its Expanded Generics Portfolio

Posted on May 16, 20235/16/23

Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States

EVERSANA
Posted on May 16, 20235/16/23

Two EVERSANA Leaders Named to Prestigious PM360 Elite 100 List

Posted on May 9, 20235/9/23

Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources

Posted on March 30, 20233/30/23

EVERSANA Named 2023 Artificial Intelligence Excellence Award Winner for Synthetic Content Program

Posted on March 23, 20233/23/23

EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis   

Posted on March 21, 20233/21/23

APACMed Names EVERSANA® Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region

Posted on February 23, 20232/23/23

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

Posted on February 22, 20232/22/23

EVERSANA® CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific

Posted on February 21, 20232/21/23

Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Analysis for Diabetic Gastroparesis Patients Treated with GIMOTI® Versus Oral Metoclopramide at the Digestive Disease Week Plenary Session